MCID: LYM008
MIFTS: 47

Lymphangiosarcoma malady

Categories: Rare diseases, Cancer diseases, Immune diseases, Skin diseases

Aliases & Classifications for Lymphangiosarcoma

About this section

Aliases & Descriptions for Lymphangiosarcoma:

Name: Lymphangiosarcoma 11 39 13 68
Stewart Treves Syndrome 48 39
Skin Lymphangiosarcoma 11 68
Angiosarcoma Associated with Chronic Lymphedema 48
Lymphangiosarcoma of Stewart and Treves 11
 
Lymphangiosarcoma Following Mastectomy 48
Postmastectomy Extremity Angiosarcoma 48
Malignant Lymphangioendothelioma 11
Stewart-Treves Syndrome 11

Classifications:



External Ids:

Disease Ontology11 DOID:2689
NCIt45 C3205, C4490

Summaries for Lymphangiosarcoma

About this section
Wikipedia:71 Lymphangiosarcoma is a rare malignant tumor which occurs in long-standing cases of primary or secondary... more...

MalaCards based summary: Lymphangiosarcoma, also known as stewart treves syndrome, is related to angiosarcoma and lymphedema. An important gene associated with Lymphangiosarcoma is TNF (Tumor Necrosis Factor), and among its related pathways are VEGFR3 signaling in lymphatic endothelium and miR-148a/miR-31/FIH1/HIF1andalpha;-Notch signaling in glioblastoma. Affiliated tissues include lymphatic vessels, endothelial and skin, and related mouse phenotypes are liver/biliary system and no phenotypic analysis.

Disease Ontology:11 A lymphatic system cancer that has material basis in endothelial cells located in lymphatic vessels.

Related Diseases for Lymphangiosarcoma

About this section

Diseases related to Lymphangiosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 94)
idRelated DiseaseScoreTop Affiliating Genes
1angiosarcoma11.2
2lymphedema10.5
3lysteria monocytoigeneses meningitis10.3FLT4, PROX1
4cervical large cell neuroendocrine carcinoma10.3HBA1, PROX1
5hypomelanosis of ito10.3FLT4, PROX1
6pilomyxoid astrocytoma10.3FLT4, PROX1
7vcl-related familial hypertrophic cardiomyopathy10.3F8, VWF
8vcp-related amyotrophic lateral sclerosis/frontotemporal dementia10.3F8, VWF
9congenital generalized lipodystrophy10.2FLT4, GJC2
10high anorectal malformation10.2F8, VWF
11chromosome 18 pericentric inversion10.2FLT4, PROX1, VEGFC
12acrofacial dysostosis, patagonia type10.2FLT4, PROX1, VEGFC
13headache10.2F8, VWF
14intracranial cysts10.2FLT4, VEGFA
15vcl-related dilated cardiomyopathy10.2F8, VWF
16sarcocystosis10.2CD34, HBA1
17cervix endometrial stromal tumor10.2CD34, HBA1
18multiple mucosal neuroma10.2CD34, DSP
19lumbar spinal canal and spinal cord meningioma10.2FLT4, GJC2, VEGFC
20intracranial hypotension10.2HBA1, PROX1, VEGFA
21vulvar dystrophy10.2CD34, HBA1
22vesiculobullous skin disease10.2FLT4, HBA1, VEGFA
23spastic ataxia 3, autosomal recessive10.2GJC2, MYC
24factitious disorder10.2FLT4, HBA1, VEGFA
25acromegaloid hypertrichosis syndrome10.2F8, VWF
26breast juvenile papillomatosis10.2CD34, HBA1
27degenerative disc disease10.2TNF, VEGFA, VWF
28hemopneumothorax10.1CD34, HBA1
29metagonimiasis10.1FLT4, VEGFA, VEGFC
30zellweger syndrome10.1TNF, VEGFA, VWF
31alpha-2-macroglobulin deficiency10.1F8, VWF
32oculodentodigital dysplasia10.1FLT4, GJC2, PROX1, VEGFC
33oppositional defiant disorder10.1TNF, VEGFA, VWF
34aortic aneurysm10.1VEGFA, VEGFC, VWF
35bilateral breast cancer10.1CD34, F8, HBA1
36fiedler's myocarditis10.1TNF, VEGFA, VWF
37lateral sclerosis10.1HBA1, LYVE1, PROX1
38dermoid cyst10.1CD34, HBA1, VWF
39gerstmann syndrome10.1CD34, F8, HBA1
40orofaciodigital syndrome 1310.1FLT4, PDPN
41ossifying fibromyxoid tumor10.1CD34, HBA1, VWF
42superior vena cava angiosarcoma10.1CD34, HBA1
43ulcerative proctitis10.1LYZ, TNF, VEGFA
44laryngeal adenoid cystic carcinoma10.1CD34, HBA1, VEGFA
45membranoproliferative glomerulonephritis10.1F8, TNF, VWF
46pleomorphic adenoma10.1CD34, HBA1, MYC
47basophil adenoma10.1CD34, HBA1, MYC
48ovarian lymphoma10.1CD34, HBA1, MYC
49skin angiosarcoma10.1CD34, HBA1, MYC
50breast mucoepidermoid carcinoma10.1CD34, HBA1, MYC

Graphical network of the top 20 diseases related to Lymphangiosarcoma:



Diseases related to lymphangiosarcoma

Symptoms & Phenotypes for Lymphangiosarcoma

About this section

MGI Mouse Phenotypes related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053709.1FLT4, LYZ, MYC, PROX1, TNF, VEGFA
2MP:00030128.2FLT4, LYZ, MYC, TNF, VEGFA, VWF
3MP:00107717.7CD34, DSP, FLT4, LYZ, MYC, PDPN
4MP:00053817.7DSP, FLT4, LYZ, MYC, PDPN, PROX1
5MP:00053847.3CD34, DSP, GJC2, LYVE1, LYZ, MYC
6MP:00053766.8CD34, F8, FLT4, LYZ, MYC, PDPN
7MP:00053856.7DSP, FLT4, LYVE1, LYZ, MYC, PDPN
8MP:00107686.6DSP, F8, FLT4, GJC2, LYZ, MYC
9MP:00053976.5CD34, F8, GJC2, LYVE1, LYZ, MYC
10MP:00053875.9CD34, F8, FLT4, GJC2, LYVE1, LYZ

Drugs & Therapeutics for Lymphangiosarcoma

About this section

Drugs for Lymphangiosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Paclitaxelapproved, vet_approvedPhase 2286433069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nab-paclitaxel
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
2Albumin-Bound PaclitaxelPhase 22864
3Antineoplastic Agents, PhytogenicPhase 25602
4Antimitotic AgentsPhase 25657
5
FluorouracilapprovedPhase 1185651-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
6
Belinostatapproved, investigationalPhase 142866323-14-0
Synonyms:
 
Belinostat
PXD 101
7Immunosuppressive AgentsPhase 113086
8Histone Deacetylase InhibitorsPhase 1569
9AntimetabolitesPhase 112054
10AndrogensPhase 11321
11Antimetabolites, AntineoplasticPhase 17361

Interventional clinical trials:

idNameStatusNCT IDPhase
1Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryCompletedNCT00217607Phase 2
2Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsCompletedNCT00413322Phase 1

Search NIH Clinical Center for Lymphangiosarcoma


Cochrane evidence based reviews: lymphangiosarcoma

Genetic Tests for Lymphangiosarcoma

About this section

Anatomical Context for Lymphangiosarcoma

About this section

MalaCards organs/tissues related to Lymphangiosarcoma:

36
Endothelial, Skin, Breast, Lymph node, Cervix, Testes, Lung

FMA organs/tissues related to Lymphangiosarcoma:

17
Lymphatic vessels

Publications for Lymphangiosarcoma

About this section

Articles related to Lymphangiosarcoma:

(show top 50)    (show all 163)
idTitleAuthorsYear
1
Modeling lymphangiosarcoma in mice. (27105012)
2016
2
Lymphangiosarcoma: Is Stewart-Treves Syndrome a Preventable Condition? (26584023)
2016
3
Stewart-Treves Phenomenon: Lymphangiosarcoma Arising in Lymphedematous Tissue Is Not a Syndrome. (25658055)
2015
4
Constitutive Activation of mTORC1 in Endothelial Cells Leads to the Development and Progression of Lymphangiosarcoma through VEGF Autocrine Signaling. (26777415)
2015
5
Lymphangiosarcoma with systemic metastases in a Japanese domestic cat. (25482607)
2015
6
Lymphangiosarcoma with bone formation of the auricle in a dog. (25716121)
2015
7
Presumed primary ocular lymphangiosarcoma with metastasis in a miniature horse. (25581559)
2015
8
Lymphangiosarcoma of mons pubis following radiotherapy for carcinoma cervix. (25404831)
2014
9
Lymphangiosarcoma in 12 dogs: a case series (1998-2013). (24612140)
2014
10
Lymphangiosarcoma with strong positivity of D2-40 and LYVE-1 presenting different clinical features from angiosarcoma. (24985547)
2014
11
Mailgnant degeneration to lymphangiosarcoma of a chronic lymphedema in the lower left extremity. (25304756)
2014
12
Lymphangiosarcoma of the scalp. (24342442)
2014
13
Lymphangiosarcoma of the scalp. (24636440)
2014
14
Complex karyotype in a case of cutaneous lymphangiosarcoma associated with chronic lymphedema of the lower limb. (24947410)
2014
15
An unusual case of skin metastasis from a breast cancer mimicking a lymphangiosarcoma. (24977428)
2014
16
Cutaneous lymphangiosarcoma following chronic lymphedema of filarial origin. (23372218)
2013
17
Chronic lymphedema of filarial origin: a very rare etiology of cutaneous lymphangiosarcoma. (23372219)
2013
18
A novel approach to treatment of lymphangiosarcoma in a boxer dog. (23560802)
2013
19
Elevated coagulation factor VIII plasma activity in a patient with lymphangiosarcoma. (23154736)
2012
20
Lymphangiosarcoma of the thorax and thoracic vertebrae in a 16-year-old girl. (22915659)
2012
21
Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS). (23342252)
2012
22
Use of surgery and mitoxantrone chemotherapy in a dog with disseminated lymphangiosarcoma. (23216040)
2012
23
Lymphangiosarcoma and filariasis. (22575002)
2012
24
Lymphangiosarcoma arising after 33 years within a background of chronic filariasis: a case report with review of literature. (22211335)
2012
25
Plasma-cell rich lymphangiosarcoma: an under-recognized variant and potential diagnostic pitfall. (22188566)
2012
26
Locally invasive lymphangiosarcoma in a young domestic shorthair. (21880529)
2011
27
Lymphangiosarcoma of the vocal cord: a rare entity defined by a D2-40 immunohistochemical and ultrastructural study. (20975065)
2011
28
FDG-PET/CT imaging in a patient with lymphangiosarcoma. (20479592)
2010
29
Lymphangiosarcoma complicating extensive congenital mixed vascular malformations. (20863270)
2010
30
Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas. (20459536)
2010
31
Fatal lymphangiosarcoma revealed by lymphoedema of the neck. (19479140)
2009
32
Lymphangiosarcoma of the arm presenting with lymphedema in a woman 16 years after mastectomy: a case report. (19918554)
2009
33
Paresis in an Asian small clawed otter (Aonyx cinereus) associated with vertebral and ischial osteolysis caused by a malignant lymphangiosarcoma. (18634215)
2008
34
Lymphangiosarcoma in the nictitating membrane of a horse. (18182523)
2008
35
Lymphangiosarcoma presenting as asymptomatic swelling of the cheek. (17317502)
2007
36
Lymphangiosarcoma in a cat. (17706243)
2007
37
Lymphangiosarcoma in two cats. (17307008)
2007
38
Case 3. Upper limb lymphangiosarcoma following breast cancer therapy. (16549844)
2006
39
Lymphangiosarcoma in a 3.5-year-old Bullmastiff bitch with vaginal prolapse, primary lymph node fibrosis and other congenital defects. (16300186)
2005
40
Lymphangiosarcoma of dogs: a review. (16300179)
2005
41
Feline lymphangiosarcoma--definitive identification using a lymphatic vascular marker. (14989700)
2004
42
Lymphangiosarcoma associated with primary lymphedema in a Bouvier des Flandres. (14765744)
2004
43
Lymphangiosarcoma in a dog treated with surgery and chemotherapy. (15031550)
2004
44
Cutaneous lymphangiosarcoma in a young dog: clinical, anatomopathological and lectinhistochemical description. (15109239)
2003
45
Metastatic lymphangiosarcoma in a horse. (12009065)
2002
46
Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable sSewart-Treves lymphangiosarcoma. (12464594)
2002
47
Chylothorax in a dog with pulmonary lymphangiosarcoma. (11204481)
2001
48
Lymphangiosarcoma (Stewart-Treves syndrome) in postmastectomy patients. (11119680)
2000
49
Stewart-Treves syndrome: lymphangiosarcoma following mastectomy. (10651369)
2000
50
Lymphangiosarcoma in a horse. (10805986)
2000

Variations for Lymphangiosarcoma

About this section

Expression for genes affiliated with Lymphangiosarcoma

About this section
Search GEO for disease gene expression data for Lymphangiosarcoma.

Pathways for genes affiliated with Lymphangiosarcoma

About this section

GO Terms for genes affiliated with Lymphangiosarcoma

About this section

Cellular components related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:00310939.1F8, VEGFA, VEGFC, VWF
2extracellular regionGO:00055767.8CD34, F8, FLT4, HBA1, LYZ, TNF

Biological processes related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1lymph vessel developmentGO:000194510.7FLT4, PROX1
2cellular response to vascular endothelial growth factor stimulusGO:003592410.5FLT4, VEGFA
3negative regulation of glucose importGO:004632510.5MYC, TNF
4blood coagulation, intrinsic pathwayGO:000759710.5F8, VWF
5induction of positive chemotaxisGO:005093010.5VEGFA, VEGFC
6oxygen transportGO:001567110.5HBA1, MYC
7positive regulation of blood vessel endothelial cell migrationGO:004353610.5VEGFA, VEGFC
8positive regulation of protein kinase C signalingGO:009003710.4FLT4, VEGFA
9positive regulation of mast cell chemotaxisGO:006075410.4VEGFA, VEGFC
10positive regulation of neuroblast proliferationGO:000205210.4VEGFA, VEGFC
11positive regulation of protein autophosphorylationGO:003195410.4VEGFA, VEGFC
12positive regulation of endothelial cell migrationGO:001059510.2FLT4, PROX1, VEGFA
13positive regulation of epithelial cell proliferationGO:005067910.0MYC, VEGFA, VEGFC
14positive regulation of angiogenesisGO:004576610.0CD34, VEGFA, VEGFC
15positive regulation of endothelial cell proliferationGO:00019389.9FLT4, PROX1, VEGFA, VEGFC
16positive regulation of cellular component movementGO:00512729.9PDPN, VEGFA
17lymphangiogenesisGO:00019469.9FLT4, PDPN, PROX1
18platelet degranulationGO:00025769.8F8, VEGFA, VEGFC, VWF
19lung developmentGO:00303249.7PDPN, PROX1, VEGFA
20platelet activationGO:00301689.7F8, PDPN, VWF
21response to woundingGO:00096119.6LYVE1, MYC, VWF
22vascular endothelial growth factor receptor signaling pathwayGO:00480109.5FLT4, VEGFA, VEGFC
23positive regulation of cell proliferationGO:00082849.5FLT4, MYC, PROX1, VEGFA, VEGFC
24positive regulation of gene expressionGO:00106289.5CD34, MYC, TNF, VEGFA
25single organismal cell-cell adhesionGO:00163379.3CD34, DSP, PDPN

Sources for Lymphangiosarcoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet